QIPP FOCUS
Murray Bywater, managing director of healthcare consultants Silicon Bridge Research, speaks to NHE about its recent survey on QIPP, GP engagement, and the long-term prospects for rebalancing acute and community care.
can be diffi cult, especially when different parts of the healthcare sector have such dif- ferent ideas about where effi ciencies can be made – and even what care should look like in this country.
M
Silicon Bridge Research decided to do some research into QIPP from the GPs’ point of view via a survey, whilst also investigating Trusts’ own activity via intensive document searches to see how different parts of the NHS are approaching QIPP.
Managing director Murray Bywater ex- plained: “A lot of our work is done with the supplier community, so we like to keep abreast of exactly what’s going on, and the biggest issues right now are clinical com- missioning and QIPP.
“We decided to poll GPs to see what their
aking sense of the savings that NHS organisations are having to make
thinking was. That was done by asking them about which approaches they thought would be most productive for the acute sec- tor in trying to achieve effi ciency goals.
“Then, in parallel with that, we looked at Trusts’ QIPP activities by doing document searches, and looked at what were the most prevalent areas they were looking at.
“We also looked at all of the available in- formation on costings and benefi ts and potential savings in healthcare, looking at the various UK and European reports that have come out recently to try to make some kind of sense out of that.”
The big fi nding was somewhat counter- intuitive: that GPs agreed with the QIPP agenda, but generally knew little about the initiative itself.
Bywater explained: “GPs are pretty much
on the money in terms of where the savings should come from, and are remarkably well aligned with what the QIPP initiatives are.
“But the one vital difference is that they didn’t recognise QIPP at all; they simply weren’t aware of it.
“It’s really being driven from the top down, from the SHAs, pushing down to the PCTs. There’s an immense variation in the amount of activity, which we think is explained by the clustering effect of PCTs.
“On the face of it, it looks like some are much more active than others, and it seems to us that’s because of the clustering, with lead PCTs who are really making all of the running having a knock-on effect.
“For acute trusts, it’s related to whether their PCTs are active or not, and whether they’ve got their own strategies or not.”
34 | national health executive Jul/Aug 11
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84